MX9700118A - Metodo para inhibir metastasis de cancer mediante administracion oral de pectina citrica modificada soluble. - Google Patents

Metodo para inhibir metastasis de cancer mediante administracion oral de pectina citrica modificada soluble.

Info

Publication number
MX9700118A
MX9700118A MX9700118A MX9700118A MX9700118A MX 9700118 A MX9700118 A MX 9700118A MX 9700118 A MX9700118 A MX 9700118A MX 9700118 A MX9700118 A MX 9700118A MX 9700118 A MX9700118 A MX 9700118A
Authority
MX
Mexico
Prior art keywords
oral administration
citrus pectin
cancer metastasis
inhibiting cancer
soluble modified
Prior art date
Application number
MX9700118A
Other languages
English (en)
Inventor
Avraham Raz
Kenneth J Pienta
Original Assignee
Barbara Ann Karmanos Inst
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23037234&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9700118(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Barbara Ann Karmanos Inst, Univ Wayne State filed Critical Barbara Ann Karmanos Inst
Publication of MX9700118A publication Critical patent/MX9700118A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Un método para el tratamiento de cáncer en mamíferos. Un individuo afectado con cáncer recibe por administracion oral una pectrina cítrica de pH modificado con inhibidores de metástasis de tumores primarios.
MX9700118A 1994-07-07 1995-06-14 Metodo para inhibir metastasis de cancer mediante administracion oral de pectina citrica modificada soluble. MX9700118A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/271,821 US5834442A (en) 1994-07-07 1994-07-07 Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin
PCT/US1995/007547 WO1996001640A1 (en) 1994-07-07 1995-06-14 Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin

Publications (1)

Publication Number Publication Date
MX9700118A true MX9700118A (es) 1997-06-28

Family

ID=23037234

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700118A MX9700118A (es) 1994-07-07 1995-06-14 Metodo para inhibir metastasis de cancer mediante administracion oral de pectina citrica modificada soluble.

Country Status (16)

Country Link
US (2) US5834442A (es)
EP (1) EP0768885B1 (es)
JP (1) JP2008111002A (es)
CN (1) CN1157567A (es)
AT (1) ATE276753T1 (es)
AU (1) AU695677B2 (es)
BR (1) BR9508245A (es)
CA (1) CA2194586A1 (es)
DE (1) DE69533550T2 (es)
DK (1) DK0768885T3 (es)
ES (1) ES2227555T3 (es)
FI (1) FI965269A (es)
MX (1) MX9700118A (es)
NO (1) NO311493B1 (es)
PT (1) PT768885E (es)
WO (1) WO1996001640A1 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020107222A1 (en) * 1993-03-01 2002-08-08 David Platt Modified polysaccharides for treatment of cancer
ES2222509T3 (es) * 1996-03-21 2005-02-01 David Platt Material de pectina modificado.
US6258383B1 (en) * 1998-08-14 2001-07-10 Lactoferrin Products Company Dietary supplement combining colostrum and lactoferrin in a mucosal delivery format
US6500807B1 (en) * 1999-02-02 2002-12-31 Safescience, Inc. Modified pectin and nucleic acid composition
KR100401456B1 (ko) * 1999-12-24 2003-10-11 (주) 한국신과학 기술센타 수컷의 생식 독성 억제에 유효한 펙틴을 포함한 약학 조성물
EP1261354A4 (en) * 2000-02-01 2004-09-15 Safescience Inc ADMINISTRATION METHOD AND SYSTEM FOR GENE THERAPY
DE10057976B4 (de) * 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
US6982255B2 (en) * 2001-03-27 2006-01-03 Anatole Klyosov Delivery of a therapeutic agent in a formulation for reduced toxicity
US6645946B1 (en) * 2001-03-27 2003-11-11 Pro-Pharmaceuticals, Inc. Delivery of a therapeutic agent in a formulation for reduced toxicity
EP1383516B1 (en) * 2001-03-27 2011-11-09 Pro-Pharmaceuticals, Inc. Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
US6914055B2 (en) * 2001-03-27 2005-07-05 Anatole Klyosov Delivery of a therapeutic agent in a formulation for reduced toxicity
US6770622B2 (en) 2001-06-08 2004-08-03 Gary A. Jarvis N-terminally truncated galectin-3 for use in treating cancer
US6680306B2 (en) * 2001-06-21 2004-01-20 Glycogenesys, Inc. Method for enhancing the effectiveness of cancer therapies
US20030004132A1 (en) * 2001-06-22 2003-01-02 Yan Chang Method and material for treating immune diseases
AU2002362613A1 (en) * 2001-09-28 2003-04-07 La Jolla Institute For Allergy And Immunology Galectins-1-and-4 in tumor development
US6890906B2 (en) * 2001-11-21 2005-05-10 Glycogenesys, Inc. Method for controlling angiogenesis in animals
US20040121981A1 (en) * 2001-11-21 2004-06-24 Glycogenesys, Inc. Method for controlling angiogenesis in animals
JP2006515647A (ja) * 2003-01-16 2006-06-01 プロ−ファーマシューティカルズ，インク． 癌の治療効果増進のための抗癌剤と修飾多糖体の併用
US20050026849A1 (en) * 2003-03-28 2005-02-03 Singh Chandra U. Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases
US20040223971A1 (en) * 2003-04-07 2004-11-11 Glycogenesys, Inc. Composition and uses of galectin antagonists
EP1617849B1 (en) * 2003-04-07 2008-06-18 Prospect Therapeutics, Inc. Composition and uses of galectin antagonists
US20050043272A1 (en) * 2003-07-11 2005-02-24 Pro-Pharmaceuticals, Inc. Compositions and methods for hydrophobic drug delivery
US20050053664A1 (en) * 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
US20050282773A1 (en) * 2004-01-14 2005-12-22 Pro-Pharmaceuticals, Inc. Modified polysaccharides in combination with anti-cancer drugs for enhanced treatment of cancer
US20070078109A1 (en) * 2004-02-13 2007-04-05 David Platt Compositions and methods used to treat acne and candida
EP1765874A1 (en) * 2004-03-26 2007-03-28 Glycogenesys, Inc. Modified pectins, compositions and methods related thereto
BRPI0512394A (pt) * 2004-06-22 2008-03-11 Pro Pharmaceuticals Inc composições e métodos para co-distribuição de fármacos anticáncer, fármacos antiangiogênicos e um polissacarìdeo
US20060074050A1 (en) * 2004-07-14 2006-04-06 Glycogenesys, Inc. Composition and method for treating hyperproliferative diseases
EP1773128A2 (en) * 2004-08-02 2007-04-18 Pro-Pharmaceuticals, Inc. Compositions and methods for the enhancement of chemotherapy with microbial cytotoxins
US8916541B2 (en) * 2011-01-05 2014-12-23 Better Health Publishing, Inc. Synergistic combination of honokiol and modified citrus pectin in cancer therapy
US9427449B2 (en) * 2005-08-26 2016-08-30 Econugenics, Inc. Binding of galectin-3 by low molecular weight pectin
WO2008011216A2 (en) * 2006-05-16 2008-01-24 Pro-Pharmaceuticals, Inc. Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
CN100394923C (zh) * 2006-05-26 2008-06-18 范晓青 低分子柑桔果胶用于调节血糖血脂和改善脂肪肝中的应用
CN101269087B (zh) * 2007-11-02 2011-11-09 中国人民解放军第四军医大学 果胶-5-氟尿嘧啶结肠癌双靶向前体药物及制备方法
CN102085214A (zh) * 2011-01-27 2011-06-08 范晓青 低分子柑橘果胶联和临床常用化疗药用于控制癌症和癌症转移扩散
AR086543A1 (es) * 2011-05-25 2014-01-08 Bg Medicine Inc Inhibidores de galectina-3 y metodos de uso de los mismos, composicion farmaceutica
EP3689250B1 (en) 2011-10-17 2022-12-07 BFLY Operations, Inc. Transmissive imaging and related apparatus and methods
BR112014015940B1 (pt) 2011-12-28 2022-08-09 Galectin Therapeutics, Inc Polissacarídeo de grau farmacêutico, composição, e seus usos
KR102071739B1 (ko) 2012-06-06 2020-01-30 갈렉틴 테라퓨틱스, 인크. 상승된 유도성 산화 질소 합성효소와 연관된 질환의 치료를 위한 갈락토-람노갈락투로네이트 조성물
AU2013315019B2 (en) 2012-09-17 2017-06-01 Galectin Therapeutics, Inc. Method for enhancing specific immunotherapies in cancer treatment
BR112015007985A8 (pt) 2012-10-10 2019-08-27 Galectin Therapeutics Inc uso do carboidrato galactose denteada para preparação de composições para tratamento de nefropatia diabética e de distúrbios associados, e suas composições
WO2014130648A1 (en) 2013-02-20 2014-08-28 Galectin Therapeutics, Inc. Method for treatment of pulmonary fibrosis
US9667889B2 (en) 2013-04-03 2017-05-30 Butterfly Network, Inc. Portable electronic devices with integrated imaging capabilities
MY197240A (en) 2016-09-02 2023-06-07 Thailand Center Of Excellence For Life Sciences Method for preparing an extract of hevea latex and composition thereof

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2132577A (en) * 1934-08-28 1938-10-11 Gen Foods Corp Method of preparing pectin
US2036922A (en) * 1935-01-31 1936-04-07 Kelco Co Alginic acid and process of making same
US2791508A (en) * 1952-08-30 1957-05-07 Rivoche Eugene Joel Food products and method of making the same
US2786763A (en) * 1953-01-06 1957-03-26 Rivoche Eugene Joel Food process
US2859115A (en) * 1953-07-07 1958-11-04 Rivoche Eugene Joel Nutrient food products and process of producing same
US3023104A (en) * 1960-07-05 1962-02-27 American Viscose Corp Food compositions incorporating cellulose crystallite aggregates
US3396034A (en) * 1964-01-20 1968-08-06 Motomco Inc Process of converting difficultly dispersible materials into a readily dispersible form and products obtained thereby
US3573058A (en) * 1967-01-30 1971-03-30 Swift & Co Microcrystalline cellulose compositions co-dried with hydrocolloids
US3764707A (en) * 1970-03-04 1973-10-09 Marine Colloids Inc Algin salt-mannogalac- for gum containing aqueous cosmetic lotion
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
GB1474990A (en) * 1974-09-02 1977-05-25 Gen Foods Corp Slow set pectin and process for preparing same
DE2442980A1 (de) * 1974-09-07 1976-03-18 Gen Foods Corp Gelierendes pektin und verfahren zu dessen herstellung
JPS5454169A (en) * 1977-10-08 1979-04-28 Asahi Chem Ind Co Ltd Compound
US4263334A (en) * 1978-05-31 1981-04-21 Fmc Corporation Water dispersible cellulosic powder and method of making the same
ATE1039T1 (de) * 1978-11-16 1982-06-15 Unilever Nv Emulsionen und verfahren zu ihrer herstellung.
US4264592A (en) * 1979-01-22 1981-04-28 Kosta Xhajanka Citrus fruit fresh cream
US4241099A (en) * 1979-02-26 1980-12-23 Tiemstra Peter J Pectin formulations, products and methods having delayed-action acidulants
US4268533A (en) * 1979-11-21 1981-05-19 General Foods Corporation Quick-set low methoxyl pectin composition
EP0052899B1 (en) * 1980-11-22 1985-01-02 Unilever N.V. Water-in-oil emulsion spread having a fat content ranging from 25 to 65 wt%, which comprises a dispersed aqueous phase containing a gelling system
US4370354A (en) * 1981-12-03 1983-01-25 Hercules Incorporated Stabilized fruit suspensions and method for preparing the same
US5308838A (en) * 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
DE3228231A1 (de) * 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
US4430349A (en) * 1982-12-23 1984-02-07 The Coca-Cola Company Artificially sweetened gelled yogurt
FR2545101B1 (fr) * 1983-04-29 1985-08-16 Agronomique Inst Nat Rech Procede de modification des pectines de betterave, produits obtenus et leurs applications
US4568673A (en) * 1984-03-20 1986-02-04 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
JPS61231967A (ja) * 1985-04-04 1986-10-16 Ajinomoto Co Inc 低脂肪食品
US4737582A (en) * 1985-06-28 1988-04-12 The Procter & Gamble Company Absorbent vegetable materials
DK153442C (da) * 1985-10-14 1988-12-19 Poul Bachmann Middel, baseret paa pektinholdigt materiale, til behandling og forebyggelse af diarre hos mennesker og dyr
DE3541945A1 (de) * 1985-11-27 1987-06-04 Lomapharm Rudolf Lohman Gmbh K Immunstimulierend wirkende polysaccharide aus zellkulturen von echinacea purpurea (l.) moench und echinacea angustifolia, d.c. verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
US4917915A (en) * 1986-03-06 1990-04-17 Lever Brothers Company Water-in-oil emulsion spread
US4686106A (en) * 1986-06-16 1987-08-11 General Foods Corporation Pectin food product
JPS63139108A (ja) * 1986-12-02 1988-06-10 Kanebo Ltd 皮膚化粧料
US4774095A (en) * 1986-12-16 1988-09-27 The Procter & Gamble Company Filling-containing, dough-based products containing cellulosic fibrils and microfibrils
US4959227A (en) * 1987-02-17 1990-09-25 Amer Moh S High dietary fiber low lactose liquid food and a method of producing same
SG47515A1 (en) * 1987-02-26 1998-04-17 Bio Polymers Pty Ltd Plant gum material and use thereof in food products
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
US4800096A (en) * 1987-05-29 1989-01-24 General Foods Corporation Pectin gelling composition
US4882187A (en) * 1987-07-02 1989-11-21 Thomas J. Lipton Inc. Edible spread and process for the preparation thereof
GB8716111D0 (en) * 1987-07-08 1987-08-12 Unilever Plc Edible plastic dispersion
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
US4828396A (en) * 1987-12-02 1989-05-09 The Nutrasweet Company Fluid processor apparatus
GB8813161D0 (en) * 1988-06-03 1988-07-06 Unilever Plc Emulsions
US5153020A (en) * 1988-06-24 1992-10-06 The Nutrasweet Company Carbohydrate cream substitute
DK350088D0 (da) * 1988-06-24 1988-06-24 Kobenhavns Pektinfabrik As Fremgangsmaade til forbedring af hoejforestret pektins geleringsegenskaber
ATE112663T1 (de) * 1988-06-24 1994-10-15 Nutrasweet Co Karbohydrat-sahneersatz.
US4911946A (en) * 1988-06-24 1990-03-27 The Nutra Sweet Company Carbohydrate cream substitute
EP0355908B1 (en) * 1988-08-17 1996-12-18 Unilever N.V. Liquid based composition comprising gelling polysaccharide capable of forming a reversible gel and a method for preparing such composition
US5071970A (en) * 1988-11-23 1991-12-10 University Of Florida Process for producing pectin with a high-to-medium methoxyl content from beet pulp
US5011701A (en) * 1988-12-30 1991-04-30 Kraft General Foods, Inc. Low calorie food products having smooth, creamy, organoleptic characteristics
ATE117512T1 (de) * 1989-11-22 1995-02-15 Unilever Nv Dispersion mit zusammenhängender lipider phase und verfahren zu ihrer herstellung.
GB8928370D0 (en) * 1989-12-15 1990-02-21 Unilever Plc Fluid composition
US5100688A (en) * 1990-02-23 1992-03-31 Cox James P Saccharide/protein gel
US4988530A (en) * 1990-03-21 1991-01-29 Gerber Products Company Soluble dietary fiber fortified beverage
ES2084171T3 (es) * 1990-06-19 1996-05-01 Mars Inc Sustitutivos de grasas y metodo de preparar microglobulos organicos.
JP3013935B2 (ja) * 1990-10-19 2000-02-28 コニカ株式会社 感熱転写記録媒体
FI920721A (fi) * 1991-02-26 1992-08-27 Hercules Inc Fett substitut
US5374444A (en) * 1991-06-28 1994-12-20 Langner; Bruce J. Fiber beverage and method of manufacture
EP0547647A1 (en) * 1991-11-12 1993-06-23 Unilever N.V. Low fat spreads and dressings
US5238699A (en) * 1991-11-27 1993-08-24 Kraft General Foods, Inc. Ready-to-eat, low/no-fat puddings and process
EP0552503A1 (fr) * 1992-01-23 1993-07-28 Romuald Dr. Kowalski Composition de sulfate de barium colloidal pour le traitement des néoplasmes du poumon
ZA931327B (en) * 1992-02-26 1994-08-25 Unilever Plc Water-continuous emulsions based on polysacharides
JP3360899B2 (ja) * 1993-10-08 2003-01-07 日本医薬品工業株式会社 癌予防・治療剤

Also Published As

Publication number Publication date
DE69533550T2 (de) 2005-09-22
JP2008111002A (ja) 2008-05-15
BR9508245A (pt) 1997-09-30
NO311493B1 (no) 2001-12-03
US5834442A (en) 1998-11-10
DE69533550D1 (de) 2004-10-28
WO1996001640A1 (en) 1996-01-25
DK0768885T3 (da) 2004-12-06
ATE276753T1 (de) 2004-10-15
EP0768885A1 (en) 1997-04-23
AU2944295A (en) 1996-02-09
CN1157567A (zh) 1997-08-20
EP0768885B1 (en) 2004-09-22
AU695677B2 (en) 1998-08-20
CA2194586A1 (en) 1996-01-25
US5895784A (en) 1999-04-20
ES2227555T3 (es) 2005-04-01
EP0768885A4 (en) 1998-04-29
FI965269A (fi) 1997-03-07
NO970039D0 (no) 1997-01-06
PT768885E (pt) 2005-01-31
NO970039L (no) 1997-02-17
FI965269A0 (fi) 1996-12-31

Similar Documents

Publication Publication Date Title
EP0768885A4 (en) METHOD FOR INHIBITING CANCER METASTASE BY ORAL ADMINISTRATION OF A MODIFIED SOLUBLE PECTIN OF CITRUS
UA70925C2 (uk) Спосіб лікування естрогенстимульованого раку
EP1146789A4 (en) TREATMENT OF CANCERS ASSOCIATED WITH OVEREXPRESSION OF HER-2 / NEU
MD1616G2 (ro) Compuşi triciclici şi metodă de inhibare a receptorului tirozin kinazei pentru factorul de creştere epidermic, compoziţie farmaceutică, metode de prevenire a implantării blastocitului şi tratament al mamiferelor
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
MX9700082A (es) Composicion que consiste de morfina, polipirrolidona y oxido de polialquileno.
SG144712A1 (en) Nordihydroguaiartic derivaties for use in treatment of tumors
AU3400297A (en) Gm-csf administration for the treatment and prevention of recurrence of brain tumors
TR199900951T2 (xx) G���s kanserinin engellenmesi i�in y�ntemler.
PH31326A (en) Methods of inhibiting breast disorders.
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
ZA949563B (en) Method for treating aphthae using dimeticone.
PL318262A1 (en) Imidazopyridine azolydinones
MD1569G2 (ro) Metodă de tratament al cancerului mamar în perioada preoperatorie
BG102087A (en) The use of pyrrolidine derivatives for the treatment of alcoholism
UA10740A (uk) Спосіб комбіhоваhого лікуваhhя раку шлуhку
AU5434899A (en) Cancer treatment
AU4209097A (en) Breast carcinoma-associated gene
UA30391A (uk) Спосіб лікування колоректального раку
UA34368A (uk) Спосіб лікування рака молочної залози
UA36341A (uk) Спосіб лікування запальних процесів навколозубних тканин
UA36385A (uk) Спосіб лікування генералізованого пародонтиту
ZA979723B (en) Methods of preventing breast cancer.
MX9709683A (es) Uso de derivados de vitamina d4 para tratamiento contra el cancer.
UA26946C2 (uk) Аhтигістаміhhий лікарський препарат

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees